4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001221355-26-000002
Director acquired 47,700 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kazam Joshua A · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-18 | Exercise or conversion : show line 1 in the form | +47,700 | 398,463 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-18 | Exercise or conversion : show line 2 in the form Restricted Stock Unit | −47,700 | 0 | D |
| 2026-06-18 | Grant or award : show line 3 in the form Restricted Stock Unit | +95,400 | 95,400 | D |
Loading xslF345X06/wk-form4_1782246909.xml…